Steven L. Zeichner, MD, PhD, the head of UVA Health’s Division of Pediatric...
Steven L. Zeichner, MD, PhD, the head of UVA Health’s Division of Pediatric Infectious Diseases, says that understanding COVID-19's effects on children is vital to slowing the pandemic.

Image source: Sanjay Suchak | UVA Communications

News • Understanding COVID-19

Why children are vital to slowing the coronavirus pandemic

Though the coronavirus disease COVID-19 so far appears to be largely sparing children, researchers are cautioning that it is critical to understand how the virus affects kids to model the pandemic accurately, limit the disease’s spread and ensure the youngest patients get the care they need.

The warning comes from Steven L. Zeichner, MD, PhD, the head of University of Virginia (UVA) Health’s Division of Pediatric Infectious Diseases, and Andrea T. Cruz, MD, MPH, a pediatric emergency medicine physician at Houston’s Baylor College of Medicine. They have authored a commentary in the journal Pediatrics accompanying a new article that reveals a small percentage of infected children become seriously ill.

Photo
Technicians Hanna Yu (foreground) and Vignesh Rajasekaran work in Zeichner's lab.

Image source: Sanjay Suchak | UVA Communications


“Many infectious diseases affect children differently than adults and understanding those differences can yield important insights,” the commentary authors write. “This will likely be true for COVID-19, just as it was for older infectious diseases.” 

Zeichner and Cruz note that there are subgroups of children who appear to be at greater risk of COVID-19 complications, particularly those who are younger, immunocompromised or have other pulmonary health problems. However, the presence of other viral infections in up to two-thirds of childhood coronavirus cases makes it very difficult to assess the true effect of COVID-19 on children, they state. (This figure is based on prior studies of children with coronaviruses detectable in the respiratory tract.)

Photo
Vignesh Rajasekaran (from left), Steven L. Zeichner and Hanna Yu are working on a vaccine for COVID-19

Image source: Sanjay Suchak | UVA Communications

While much remains unknown, Cruz and Zeichner caution that children, even asymptomatic children, could play a “major role” in disease transmission. For example, they cite a study that found the virus remained in children’s stool for several weeks after diagnosis. That, combined with other routes of transmission such as nasal secretions, could pose a major challenge for schools, day care centers and the children’s families, they note. “Since many children infected with COVID-19 appear to have have mild symptoms, or even no symptoms at all, it is important to practice all the social distancing, hygiene and other precautions being recommended by public health authorities to minimize transmission from children to others, including family members who may be at greater risk from the infection, such as grandparents or family members with chronic medical conditions,” said Zeichner, who is working on innovative potential COVID-19 vaccines in his lab. “In addition, studies of the reasons why children are affected differently than adults by the infection may yield insights that can be helpful in understanding the disease and ways to treat or prevent it.”


Source: University of Virginia

19.03.2020

Read all latest stories

Related articles

Photo

News • Coronavirus risk assessment

Investigating the risk of severe Covid-19 in children

So far, little research has been done on the risk of children being seriously affected by Covid-19 when the schools were open. A study from Karolinska Institutet has now shown that one child in…

Photo

News • Research shows

Children are silent spreaders of COVID-19 virus

In the most comprehensive study of COVID-19 pediatric patients to date, Massachusetts General Hospital (MGH) and Mass General Hospital for Children (MGHfC) researchers provide critical data showing…

Photo

News • Protein-based nanostructures show promise

Nanoparticles to neutralise SARS-CoV-2

Researchers at the Universitat Autònoma de Barcelona (UAB) have developed a new type of nanoparticles inspired by the structure of amyloids, capable of neutralising the SARS-CoV-2 virus.

Related products

Calypso F – Multifunctional DR system

DR

GMM Group · Calypso F – Multifunctional DR system

General Medical Merate S.p.A. (GMM Group)
Fujifilm Wako – Autokit Total Ketone Bodies Assay

Clinical Chemistry

Fujifilm Wako – Autokit Total Ketone Bodies Assay

FUJIFILM Wako Chemicals Europe GmbH
Opera Sharp Evolution – Remote-controlled system

Flatpanel Fluoro

GMM Group · Opera Sharp Evolution – Remote-controlled system

General Medical Merate S.p.A. (GMM Group)
Subscribe to Newsletter